Hemodialysis Procedure Does Not Affect the Levels of sICAM-1 and sVCAM-1 in Patients with End Stage Renal Disease

REFERENCES

• Levey, A.; Beto, J.; Coronado, B E.; Eknoyan, G.; Foley, R N.; Kasiske, B L.; Klag, M J.; Mailloux, L U.; Manske, C L.; Meyer, K B.; Parfrey, P S.; Pfeffer, M A.; Wenger, N K.; Wilson, P W.; Wright, J T., Jr. Controlling the epidemic of cardiovascular disease in chronic renal failure, What do we know? What do we need to learn? Where do we go from here? Am. J. Kidney Dis. 1998, 32, 853–906. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Walter, R.; Mischak, H.; Haller, H. Hemodialysis, atherosclerosis and inflammation-identifying molecular mechanisms of chronic vascular diseases in ESRD patients Nephrol. Dial. Transplant. 2002, 17 (Suppl. 3), 24–29. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Hansson, G K. Immune mechanism in atherosclerosis Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1876–1890. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Johnson-Leger, C.; Aurrand-Lions, M.; Imhof, B A. The parting of the endothelium, miracle, or simply a junctional affair? J. Cell. Sci. 2000, 113, 921–933. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Masinovsky, B.; Urdal, D.; Gallatin, W M. IL-4 acts synergistically with IL-1b to promote lymphocyte adhesion by induction of vascular cell adhesion molecule-1 J. Immunol. 1990, 145, 2886–2895. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Thornhill, M H.; Wellicome, S M.; Mahiouz, D L.; Lanchbury, J S.; Kyan-Aung, U.; Haskard, D O. Tumor necrosis factor combines with IL-4 or interferon-gamma to selectively enhanced epithelial cell adhesiveness for T-cells. The contribution of vascular cell adhesion molecule-1 dependent and independent mechanisms J. Immunol. 1991, 146, 592–598. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Frostegard, J.; Haegerstrand, A.; Gidlund, M.; Nilsson, J. Biologically modified LDL increases the adhesive properties of endothelial cells Atherosclerosis 1991, 90, 119–126. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Cybulsky, M I.; Gimbrone, M A. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherosclerosis Science 1991, 251, 788–791. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Morandini, R.; Boeynaems, J M.; Duhant, X.; Jacquemotte, F.; Kinnaert, E.; Ghanem, G. SODs are involved in the regulation of ICAM expression in human melanoma and endothelial cells Cell. Mol. Biol. 1999, 45, 1053–1063. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Walpola, P L.; Gotlieb, A I.; Cybulsky, M I.; Langille, B L. Expression of ICAM-1 and VCAM-1 and monocyte adherence in arteries exposed to altered shear stress Arterioscler. Thromb. Vasc. Biol. 1995, 15, 2–10. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Nakai, K.; Itoh, C.; Kawazoe, K.; Miura, Y.; Sotoyanagi, H.; Hotta, K.; Itoh, T.; Kamata, J.; Hiramori, K. Concentration of soluble vascular cell adhesion molecule-1 (s VCAM-1) correlated with expression of VCAM-1 mRNA in the human atherosclerotic aorta Coron. Artery Dis. 1995, 6, 497–502. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Pigott, R.; Dillon, L P.; Hemingway, I H.; Gearing, A J. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells Biochem. Biophys. Res. Commun. 1992, 187, 584–589. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Hwang, S J.; Ballantyne, C M.; Sharrett, A R.; Smith, L C.; Davis, C E.; Gotto, A M., Jr., Boerwinkle, E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-Selectin in carotid atherosclerosis and incident coronary heart disease cases. [The Atherosclerosis In Communities (ARIC) Study] Circulation 1997, 96, 4219–4225. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Van der Meer, I M.; de Maat, M P.; Bots, M L.; Breteler, M M.; Meijer, J.; Kiliaan, A J.; Hofman, A.; Witteman, J C. Inflammatory mediators and cell adhesion molecules as indicators of severity of atherosclerosis (The Rotterdam Study) Arterioscler. Thromb. Vasc. Biol. 2002, 22, 838–842. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Huo, Y.; Haferi-Moghamad, A.; Ley, K. Role of vascular cell adhesion molecule-1 and fibronectin connecting segment-1 in monocyte rolling and adhesion on early atherosclerotic lesions Circ. Res. 2000, 87, 153–159. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rizzoni, D.; Muiesan, M L.; Porteri, E.; Castellano, M.; Salvetti, M.; Monteduro, C.; De Ciuceis, C.; Boari, G.; Valentini, U.; Cimino, A.; Sleiman, I.; Agabiti-Rosei, E. Circulating adhesion molecules and carotid artery structural changes in patients withnon insulin dependent diabetes mellitus J. Hum. Hypertens. 2003, 17, 463–470. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• DeSouza, C A.; Dengel, D R.; Macko, R F.; Cox, K.; Seals, D R. Elevated levels of circulated cell adhesion molecules in uncomplicated essential hypertension Am. J. Hypertens. 1997, 10, 1335–1341. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hackman, A.; Abe, Y.; Insull, W., Jr., Pownall, H.; Smith, L.; Dunn, K.; Gotto, A M., Jr., Ballantyne, C M. Levels of soluble adhesion molecules in patients with dyslipidemia Circulation 1996, 93, 1334–1338. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Rabb, H.; Calderon, E.; Bittle, P A.; Ramirez, G. Alteration in soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in hemodialysis patients Am. J. Kidney Dis. 1996, 27, 239–243. [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Thylen, P.; Fernvik, E.; Lundahl, J.; Lins, L E.; Jacobson, S H. Monocyte and granulocyte CD11b/cd18, CD62L expression and sICAM-1 concentration in the intradialytic period Nephron 1996, 74, 275–282. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bonomini, M.; Reale, M.; Santarelli, P.; Stuard, S.; Settefrati, N.; Albertazzi, A. Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients Nephron 1998, 79, 399–407. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Papayianni, A.; Alexopoulos, E.; Giamalis, P.; Gionanlis, L.; Belechri, A M.; Koukoudis, P.; Memmos, D. Circulating levels of ICAM-1, VCAM-1 and MCP-1 are increased in hemodialysis patients, association with inflammation, dyslipidemia and vascular events Nephrol. Dial. Transplant. 2002, 17, 435–441. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Mrowka, C.; Heintz, B.; Sieberth, H G. Is dialysis membrane type responsible for increased circulating adhesion molecules during chronic hemodialysis? Clin. Nephrol. 1999, 52 (5), 312–321. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Pflederer, B R.; Torrey, C.; Priester-Coary, A.; Lau, A H.; Daugirdas, J T. Estimating equilibrated Kt/V from an intradialytic sample: effects of access and cardiopulmonary recirculations Kidney Int. 1995, 48, 832–837. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Daugirdas, J T.; Burke, M S.; Balter, P.; Priester-Coary, A.; Majka, T. Screening for extreme postdialysis urea rebound using the Smye method: patients with access recirculation identified when a slow flow method is not used to draw the postdialysis blood Am. J. Kidney Dis. 1996, 28, 727–731. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Van Beaumont, W. Evaluation of hemoconcentration from hematocrit measurements J. Appl. Phys. 1972, 32 (5), 712–713.
   PubMed Web of Science ®Google Scholar
• Boulbou, M S.; Gourgoulianis, K I.; Petinaki, E A.; Klisiaris, V K.; Maniatis, A N.; Molyvdas, P A. Pulmonary function and circulating adhesion molecules in patients with diabetes mellitus Can. Respir. J. 2003, 10, 259–264. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Elhadd, T A.; Kennedy, G.; Robb, R.; McLaren, M.; Jung, R T.; Belch, J J. Elevated soluble adhesion molecules E-selectin and intercellular cell adhesion molecule-1 in type-2 diabetic patients with and without asymptomatic peripheral arterial disease Int. Angiol. 2004, 23, 128–133. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Stefanidis, I.; Wurth, P.; Mertens, P R.; Ikonomov, V.; Philippidis, G.; Golphinopoulos, S.; Makropoulos, V.; Liakopoulos, V.; Mann, H.; Heintz, B. Plasma endothelin-1 in hemodialysis treatment—The influence of hypertension J. Cardiovasc. Pharmacol. 2004, 44, S43–S48. [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Warrens, A N.; Cassidy, M J.; Takahashi, K.; Ghatei, M A.; Bloom, S R. Endothelin in renal failure Nephrol. Dial. Transplant. 1990, 5, 418–422. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Deray, G.; Carayon, A.; Maistre, G.; Benhmida, M.; Masson, F.; Barthelemy, C.; Petitclerc, T.; Jacobs, C. Endothelin in chronic renal failure Nephrol. Dial. Transplant. 1992, 7, 300–305. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Meier, P.; von Fliedner, V.; Markert, M.; van Melle, G.; Deppisch, R.; Wauters, J P. One year immunological evaluation of chronic hemodialysis end stage renal disease patients Blood Purif. 2000, 18, 128–137. [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Konstantopoulos, K.; Kukreti, S.; Smith, S W.; McIntyre, L V. Endothelial P-selectin and VCAM-1 each can function as primary adhesive mechanisms for T cells under conditions of flow J. Leukoc. Biol. 1997, 61, 179–187. [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Beaman, M.; Michael, J.; MacLennan, I C.; Adu, D. T-cell-independent and T-cell-dependent antibody responses in patients with chronic renal failure Nephrol. Dial. Transplant. 1989, 4, 216–221. [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Eleftheriadis, T.; Papazisis, K.; Kortsaris, A.; Vayonas, G.; Voyatzi, S.; Vargemezis, V. Impaired T-cell proliferation and zeta chain phosphorylation after stimulation with staphylococcal enterotoxin-B in hemodialysis patients Nephron Clin. Pract. 2004, 96, c15–c20. [PUBMED], [INFOTRIEVE], [CROSSREF]
   Google Scholar
• Springer, T A. Adhesion receptors of the immune system Nature 1990, 346, 425–434. [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Luger, A.; Kovarik, J.; Stummvoll, H K.; Urbanska, A.; Luger, T A. Blood membrane interaction in hemodialysis leads to increased cytokine production Kidney Int. 1987, 32 (1), 83–88.
   Google Scholar
• Pereira, B J.; Shapiro, L.; King, A J.; Falagas, M E.; Strom, J A.; Dinarello, C A. Plasma levels of IL-1b, TNFa and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients Kidney Int. 1994, 45, 890–896. [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar